BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaur V, Garg T, Rath G, Goyal AK. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target 2014;22:859-70. [PMID: 25101945 DOI: 10.3109/1061186X.2014.947295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Halder J, Pradhan D, Kar B, Ghosh G, Rath G. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer. Nanomedicine 2021;:102494. [PMID: 34775061 DOI: 10.1016/j.nano.2021.102494] [Reference Citation Analysis]
2 Mu Q, Yu J, McConnachie LA, Kraft JC, Gao Y, Gulati GK, Ho RJY. Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook. J Drug Target 2018;26:435-47. [PMID: 29285948 DOI: 10.1080/1061186X.2017.1419363] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
3 Tao X, Mao S, Zhang Q, Yu H, Li Y, He X, Yang S, Zhang Z, Yi Z, Song Y, Feng X. Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection. Nanoscale Res Lett 2021;16:132. [PMID: 34406517 DOI: 10.1186/s11671-021-03584-1] [Reference Citation Analysis]